Protocol summary
-
Study aim
-
Investigation and Comparison of the Synergistic Effects of tDCS, tACS, and NMES Combined with Exercise Therapy on Clinical Outcomes and EEG Activity in Women with Patellofemoral Pain Syndrome
-
Design
-
A three-arm parallel, double-blind, randomized clinical trial conducted on 42 patients. Randomization was performed using the RAND function in Microsoft Excel
-
Settings and conduct
-
42 eligible women with patellofemoral pain syndrome will be randomly assigned to one of three intervention groups. Initial assessments will be conducted at the physiotherapy laboratory of the School of Rehabilitation. Subsequently, participants will undergo 12 treatment sessions, held three times per week over a continuous period of four weeks, at the physiotherapy clinic of the same school. Post-treatment assessments will be carried out after the completion of the intervention sessions and in one month followup. Both the participants and the physiotherapist responsible for pre- and post-treatment evaluations will be blinded to the group assignments.
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria: Women aged between 18 and 35 years, A history of unilateral or bilateral pain around or behind the patella,Tenderness to palpation over the medial or lateral facet of the patella, Non-traumatic onset of symptoms
Exclusion Criteria: History of knee injuries such as meniscal, tendon, or ligament damage, History of partial or complete patellar dislocation, Any musculoskeletal condition affecting other joints in the lower limbs or the backContraindications for the use of neuromodulation techniques
-
Intervention groups
-
Group 1: NMES+Exe
Group 2: tDCS+Exe
Group 3: tACS+Exe
-
Main outcome variables
-
Pain intensity, Functional activity level, Functional performance, Dynamic balance, Mean relative and absolute power of the delta, theta, alpha1 and alpha2 frequency bands
General information
-
Reason for update
-
1.Change in the names of the participant recruitment centers due to the lack of cooperation from the previously designated centers in posting recruitment advertisements.
2. Change in the person responsible for responding to scientific inquiries about the study, from the student researcher to the study supervisor.
3. Revision of the publication plan due to the lack of a final decision regarding the publication of information related to the study protocol and dataset
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT20250408065257N1
Registration date:
2025-05-12, 1404/02/22
Registration timing:
prospective
Last update:
2026-11-20, 1405/08/29
Update count:
1
-
Registration date
-
2025-05-12, 1404/02/22
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2025-05-22, 1404/03/01
-
Expected recruitment end date
-
2026-09-22, 1405/06/31
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Synergistic Effects of transcranial Direct Current Stimulation, transcranial Alternative Current Stimulation and Neuromuscular Electrical Stimulation Combined with Exercise Therapy on Clinical Outcomes and Electroencephalographic Activity in Women with Patellofemoral Pain Syndrome
-
Public title
-
Effects of Central and Peripheral Stimulation Combined with Exercise in Women with Patellofemoral Pain Syndrome
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Women Aged Between 18 and 35 Years
History of Unilateral or Bilateral Pain Around or Behind the Patella, Exacerbated by at Least Two of the Following Activities: Squatting, Going Up or Down Stairs, or Prolonged Sitting with Knees Bent
Tenderness to Palpation Over the Medial or Lateral Facets of the Patella
Pain During Isometric Contraction of the Quadriceps Against Resistance Applied Above the Patella, and Pain During Resisted Knee Extension at Various Degrees of Flexion
Non-traumatic Onset of Symptoms
Patellofemoral Joint Pain for at Least the Past 3 Months
Minimum Literacy Level Equivalent to Completion of Middle School
Exclusion criteria:
History of Knee Injuries such as Meniscal, Tendon, or Ligament Damage
History of Patellar Subluxation or Dislocation
Any Condition Affecting Other Joints Involving the Lower Limbs or the Back
History of Fractures in the Spine or Lower Limbs
History of Surgery or Arthroscopy in any of the Lower Limb Joints
History of Head Trauma, Neurological Disorders, or Mental Health Issues
Contraindications for Neuromodulation such as Pregnancy, Presence of Metal Implants, Epilepsy, History of Skull Fracture, or Cardiac Pacemaker
-
Age
-
From 18 years old to 35 years old
-
Gender
-
Female
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Outcome assessor
-
Sample size
-
Target sample size:
42
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
All Eligible Patients will be Randomly Assigned Using Block Randomization with Blocks of Size 6, Equally Distributed into Three Groups (with an Allocation Ratio of 1:1:1): NMES+EX, tDCS+EX, and tACS+EX. The Group Allocation for Each Participant will be Concealed Using Sealed Envelopes.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
This study is double-blinded. Both participants and the outcome assessor will be blinded to the group allocation. All assessments will be performed by a physiotherapist who is independent of the research team and will only work with participant codes. In the tDCS and tACS groups, 20-minute brain stimulation is delivered prior to the exercise in a seated and relaxed position, using a constant intensity of 2 mA. Electrode placement is identical in both groups. The device interface and settings are indistinguishable, and the display screen is masked to prevent revealing the type of current. Participants are informed that the study involves different types of brain stimulation without specifying which type. In the NMES group, electrical stimulation is applied simultaneously with strengthening exercises, which makes complete blinding of participants in this group not feasible. However, the assessor remains blinded throughout and is not involved in any part of the intervention.
-
Placebo
-
Not used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2025-04-24, 1404/02/04
-
Ethics committee reference number
-
IR.TUMS.FNM.REC.1404.046
Health conditions studied
1
-
Description of health condition studied
-
Patellofemoral Pain Syndrome
-
ICD-10 code
-
-
ICD-10 code description
-
Primary outcomes
1
-
Description
-
Pain Intensity on Visual Analogue Scale
-
Timepoint
-
Pain intensity will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention.
-
Method of measurement
-
Visual Analogue Scale
Secondary outcomes
1
-
Description
-
Functional Activity Level
-
Timepoint
-
Functional Activity Level will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention
-
Method of measurement
-
Kujala Questionnaire
2
-
Description
-
Dynamic Balance
-
Timepoint
-
Dynamic Balance will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention
-
Method of measurement
-
Y-balance test
3
-
Description
-
Functional Performance
-
Timepoint
-
Functional Performance will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention
-
Method of measurement
-
Step-Down test
4
-
Description
-
Mean relative power of the EEG frequency bands
-
Timepoint
-
Mean relative power of the EEG frequency bands will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention
-
Method of measurement
-
Recording with an EEG device and measurement using sLORETA software
5
-
Description
-
Mean absolute power of the EEG frequency bands
-
Timepoint
-
Mean absolute power of the EEG frequency bands will be measured at the beginning of the study (before the start of the intervention), after completing 12 intervention sessions, and one month after the end of the intervention
-
Method of measurement
-
Recording with an EEG device and measurement using sLORETA software
Intervention groups
1
-
Description
-
Intervention group: NMES and Exercise Therapy
-
Category
-
Rehabilitation
2
-
Description
-
Intervention group: tDCS and Exercise Therapy
-
Category
-
Rehabilitation
3
-
Description
-
Intervention group: tACS and Exercise Therapy
-
Category
-
Rehabilitation
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Tehran University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
No - There is not a plan to make this available
-
Justification/reason for indecision/not sharing IPD
-
There is no further information
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
No - There is not a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
No - There is not a plan to make this available
-
Data Dictionary
-
No - There is not a plan to make this available